Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

In some instances, a man's prostate cancer biopsy can indicate perineural invasion. In an exclusive interview, an expert ...

Actor Colin Egglesfield has been diagnosed with cancer for the third time in his life. The former "All My Children" star ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

State Rep. Charlie Meier released a message Monday that wasn’t about politics or state government issues. It was a personal ...

In 2024, Feng received the “Mentorship Award” from ASTRO. In December, the American Society for Clinical Oncology (ASCO) ...

High intensity focused ultrasound (HIFU) is a novel prostate cancer treatment that minimizes side effect while destroying ...

"All My Children" star Colin Egglesfield talked about the support he's received after revealing his third cancer diagnosis ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

This milestone builds on Clarity's earlier receipt of an FTD for 64 Cu-SAR-bisPSMA in patients with suspected metastasis of prostate cancer who are candidates for initial definitive therapy [1]. These ...